Pre-operative management of periodontal procedures for bleeding disorders
Keywords:
-Abstract
-
Downloads
Download data is not yet available.
References
1. Hewson, I.D., et al., Consensus statement by hospital based dentists providing dental treatment for patients with inherited bleeding disorders. Aust Dent J, 2011. 56(2): p. 221-6.
2. Neha Bansal, M.J., Narinder Dev Gupta, Pradeep Shukla Clinical guidelines for periodontal management of idiopathic thrombocytopenic purpura: Current considerations. International Journal of Oral Health Sciences, 2017.
3. Abed, H. and A. Ainousa, Dental management of patients with inherited bleeding disorders: a multidisciplinary approach. Gen Dent, 2017. 65(6): p. 56-60.
4. Andrew Brewer, M.E.C., GUIDELINES FOR DENTAL TREATMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS World Federation of Hemophilia Dental Committee, 2006
5. Heiland, M., M. Weber, and R. Schmelzle, Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report. J Oral Maxillofac Surg, 2003. 61(11): p. 1350-3.
6. Srivastava, A., et al., Guidelines for the management of hemophilia. Haemophilia, 2013. 19(1): p. e1-47.
7. Kazancioglu, H.O., et al., The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial. Turk J Haematol, 2013. 30(1): p. 19-24.
8. Lockhart, P.B., et al., Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs. Br Dent J, 2003. 195(9): p. 495-501.
9. Escobar, M., et al., Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia, 2012. 18(6): p. 971-81.
10. Anderson, J.A., et al., Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J, 2013. 215(10): p. 497-504.
11. Siderov, J., Preparing tranexamic acid 4.8% mouthwash. Australian Prescriber 2003. 26
12. Lei Jin, H.-W.J., Effect of Desmopressin on Platelet Aggregation and Blood Loss in Patients Undergoing Valvular Heart Surgery. Chinese Medical Journal 2015 128 (5): p. 4.
13. Lockhart, P.B., et al., Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease. Br Dent J, 2003. 195(8): p. 439-45.
14. Rattray, B., D.J. Nugent, and G. Young, Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia, 2006. 12(5): p. 514-7.
15. Kuriyama, T., et al., Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2000. 90(5): p. 600-8.
16. American Academy of Pediatric, D., Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent, 2013. 35(5): p. E185-93.
17. British Committee for Standards in Haematology General Haematology Task, F., Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol, 2003. 120(4): p. 574-96.
18. Peyvandi, F., et al., Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost, 2012. 10(4): p. 615-21.
19. Crispian Scully, P.D.D., Navdeep Kumar, Special Care in Dentistry: Handbook of Oral Healthcare. Vol. 1. 2007, UK: Churchill Livingstone.
20. Organisation, A.H.C.D., GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH HAEMOPHILIA UNDERGOING SURGICAL PROCEDURES 2010.
21. Giancarlo Castaman, S.L., Augusto B Federici, Response to desmopressin is influenced by the genotype and phenotype in type1 von Willebrand disease(VWD) : results from the European Study MCMDM-1VWD. HEMOSTASIS, THROMBOSIS,AND VASCULAR BIOLOGY, 2008 111: p. 9.
22. Mannucci, P.M., et al., Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus, 2009. 7(2): p. 117-26.
23. Stuart H. Orkin, M., David G. Nathan, MD, David Ginsburg, MD, A. Thomas Look, MD, David E. Fisher, MD, PhD and Samuel Lux, IV, MD, Nathan and Oski's Hematology and Oncology of Infancy and Childhood. 8 ed. 2015.
24. Bolton-Maggs, P.H., THE RARE COAGULATION DISORDERS. TREATMENT Of HEMOPHILIA, 2006. 39.
25. Santoro, C., et al., Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients. Haemophilia, 2010. 16(5): p. 805-12.
2. Neha Bansal, M.J., Narinder Dev Gupta, Pradeep Shukla Clinical guidelines for periodontal management of idiopathic thrombocytopenic purpura: Current considerations. International Journal of Oral Health Sciences, 2017.
3. Abed, H. and A. Ainousa, Dental management of patients with inherited bleeding disorders: a multidisciplinary approach. Gen Dent, 2017. 65(6): p. 56-60.
4. Andrew Brewer, M.E.C., GUIDELINES FOR DENTAL TREATMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS World Federation of Hemophilia Dental Committee, 2006
5. Heiland, M., M. Weber, and R. Schmelzle, Life-threatening bleeding after dental extraction in a hemophilia A patient with inhibitors to factor VIII: a case report. J Oral Maxillofac Surg, 2003. 61(11): p. 1350-3.
6. Srivastava, A., et al., Guidelines for the management of hemophilia. Haemophilia, 2013. 19(1): p. e1-47.
7. Kazancioglu, H.O., et al., The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial. Turk J Haematol, 2013. 30(1): p. 19-24.
8. Lockhart, P.B., et al., Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs. Br Dent J, 2003. 195(9): p. 495-501.
9. Escobar, M., et al., Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia, 2012. 18(6): p. 971-81.
10. Anderson, J.A., et al., Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J, 2013. 215(10): p. 497-504.
11. Siderov, J., Preparing tranexamic acid 4.8% mouthwash. Australian Prescriber 2003. 26
12. Lei Jin, H.-W.J., Effect of Desmopressin on Platelet Aggregation and Blood Loss in Patients Undergoing Valvular Heart Surgery. Chinese Medical Journal 2015 128 (5): p. 4.
13. Lockhart, P.B., et al., Dental management considerations for the patient with an acquired coagulopathy. Part 1: Coagulopathies from systemic disease. Br Dent J, 2003. 195(8): p. 439-45.
14. Rattray, B., D.J. Nugent, and G. Young, Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia, 2006. 12(5): p. 514-7.
15. Kuriyama, T., et al., Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2000. 90(5): p. 600-8.
16. American Academy of Pediatric, D., Guideline on dental management of pediatric patients receiving chemotherapy, hematopoietic cell transplantation, and/or radiation. Pediatr Dent, 2013. 35(5): p. E185-93.
17. British Committee for Standards in Haematology General Haematology Task, F., Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol, 2003. 120(4): p. 574-96.
18. Peyvandi, F., et al., Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost, 2012. 10(4): p. 615-21.
19. Crispian Scully, P.D.D., Navdeep Kumar, Special Care in Dentistry: Handbook of Oral Healthcare. Vol. 1. 2007, UK: Churchill Livingstone.
20. Organisation, A.H.C.D., GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH HAEMOPHILIA UNDERGOING SURGICAL PROCEDURES 2010.
21. Giancarlo Castaman, S.L., Augusto B Federici, Response to desmopressin is influenced by the genotype and phenotype in type1 von Willebrand disease(VWD) : results from the European Study MCMDM-1VWD. HEMOSTASIS, THROMBOSIS,AND VASCULAR BIOLOGY, 2008 111: p. 9.
22. Mannucci, P.M., et al., Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfus, 2009. 7(2): p. 117-26.
23. Stuart H. Orkin, M., David G. Nathan, MD, David Ginsburg, MD, A. Thomas Look, MD, David E. Fisher, MD, PhD and Samuel Lux, IV, MD, Nathan and Oski's Hematology and Oncology of Infancy and Childhood. 8 ed. 2015.
24. Bolton-Maggs, P.H., THE RARE COAGULATION DISORDERS. TREATMENT Of HEMOPHILIA, 2006. 39.
25. Santoro, C., et al., Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients. Haemophilia, 2010. 16(5): p. 805-12.
Downloads
Published
2020-06-15
Issue
Section
บทความฟื้นวิชา (Literature review)
